Skip to main
SMLR

Semler Scientific (SMLR) Stock Forecast & Price Target

Semler Scientific (SMLR) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Semler Scientific Inc. operates in the healthcare technology sector, focusing on proprietary solutions that enhance clinical effectiveness and efficiency for healthcare providers. The company's prominent vascular-testing product, QuantaFlo, not only generates substantial cash flows but also supports its strategic investment in Bitcoin as a treasury reserve asset. Additionally, the ongoing merger-related dynamics present a potential upside, as the current market discount to the implied deal value indicates an opportunity for share price appreciation, particularly as investors recognize the fundamentals driving this transaction.

Bears say

Semler Scientific Inc. faces significant market skepticism, as evidenced by a discount in its implied value linked to the performance of Strive’s share price, which may lead to renegotiation pressures. The company's reliance on the fluctuating value of bitcoin for its treasury reserve could exacerbate financial instability, especially given recent multi-day price slumps in the cryptocurrency market. This volatility creates uncertainty regarding the health of Semler's operations and its ability to maintain cash flows necessary for thriving in its primary healthcare technology solutions business.

Semler Scientific (SMLR) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Semler Scientific and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Semler Scientific (SMLR) Forecast

Analysts have given Semler Scientific (SMLR) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Semler Scientific (SMLR) has a Strong Buy consensus rating as of Feb 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Semler Scientific (SMLR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.